Asterias Stock Valuation

What would the acquisition value of Asterias Biotherapeutics be today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Asterias Biotherapeutics, is its stock price multiplied by the total number of shares outstanding, calculating Asterias Biotherapeutics' enterprise value requires a different approach. It uses Asterias Biotherapeutics' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Tangible Asset Value is likely to gain to about 44.8 M in 2022, whereas Free Cash Flow is likely to drop (21.1 M) in 2022.
Asterias Biotherapeutics seems to be undervalued based on Macroaxis valuation methodology. Our model approximates the value of Asterias Biotherapeutics from analyzing the firm fundamentals such as Return On Equity of (93.17) %, shares outstanding of 55.66 M, and Profit Margin of (4.60) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor acquiring undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Asterias Biotherapeutics Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Asterias Biotherapeutics's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Asterias Biotherapeutics' intrinsic value based on its ongoing forecasts of Asterias Biotherapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Asterias Biotherapeutics' closest peers. When choosing an evaluation method for Asterias Biotherapeutics, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Asterias Biotherapeutics Investments

12.78 Million

Asterias Valuation Drivers Correlation

Many accounts on the financial statements of Asterias Biotherapeutics are highly interrelated and sometimes correlated. Consequently, when conducting Asterias's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Asterias
Click cells to compare fundamentals

Asterias Valuation Trend

Knowing Asterias Biotherapeutics' actual value is paramount for traders to make sound investment determinations. Asterias Biotherapeutics' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Asterias Biotherapeutics' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Asterias Biotherapeutics' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Asterias Biotherapeutics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Asterias Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Asterias Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Asterias Biotherapeutics competition to find correlations between indicators driving Asterias Biotherapeutics's intrinsic value. More Info.
Asterias Biotherapeutics is number one stock in price to sales category among related companies. It is rated below average in price to earning category among related companies . Price to Earnings Ratio is likely to drop to -9.08 in 2022. Earnings Before Interest Taxes and Depreciation Amortization EBITDA is likely to drop to about (29.9 M) in 2022. Comparative valuation analysis is a catch-all model that can be used if you cannot value Asterias Biotherapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Asterias Biotherapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Asterias Biotherapeutics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Asterias Biotherapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Asterias Biotherapeutics and how it compares across the competition.

Asterias Biotherapeutics Current Valuation Indicators

Valuation refers to the process of determining the present value of Asterias Biotherapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Asterias we look at many different elements of the entity such as Asterias's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Asterias Biotherapeutics' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Asterias Biotherapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Asterias Biotherapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Asterias Biotherapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Asterias Biotherapeutics' worth.
Check out Trending Equities. Note that the Asterias Biotherapeutics information on this page should be used as a complementary analysis to other Asterias Biotherapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Tools for Asterias Stock

When running Asterias Biotherapeutics price analysis, check to measure Asterias Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Asterias Biotherapeutics is operating at the current time. Most of Asterias Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Asterias Biotherapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Asterias Biotherapeutics' price. Additionally, you may evaluate how the addition of Asterias Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments